IDEAS home Printed from https://ideas.repec.org/a/igg/jabim0/v4y2013i4p35-47.html
   My bibliography  Save this article

Internationalization Strategies of Chinese Pharmaceutical Firms

Author

Listed:
  • Xiaohui Li

    (Department of Business and Administration, Dongling Economics and Management School, Beijing University of Science and Technology, Beijing, China)

  • Yunshan Lian

    (H. Wayne Huizenga School of Business, Nova Southeastern University, Ft. Lauderdale, FL, USA)

  • Jingyuan Zhao

    (University of Toronto, Toronto, Canada)

Abstract

Chinese pharmaceutical market value is about USD 110 billion in 2009, and it has become the world’s second largest market. Chinese pharmaceutical firms are becoming a growing player in global pharmaceutical chains. In this paper, sample firms are selected and surveyed with a focus on effective internationalization strategies and paths, through an empirical research, this paper summarizes the internationalization of Chinese pharmaceutical firms, and finds the effective strategies of international market entry are product upgrading along the industrial chains, international certification and cooperation, outsourcing and licensing, and other paths of overseas expansion. The implication for pharmaceutical firms in emerging market is to choose the suitable strategies based on own advantages, learn from the experience of other emerging market and domestic leading companies of internationalization, and gradually enter the standard market. This study not only provides international market entry strategies for the latecomers of Chinese pharmaceutical firms, but also enriches the internationalization theory of emerging market.

Suggested Citation

  • Xiaohui Li & Yunshan Lian & Jingyuan Zhao, 2013. "Internationalization Strategies of Chinese Pharmaceutical Firms," International Journal of Asian Business and Information Management (IJABIM), IGI Global, vol. 4(4), pages 35-47, October.
    • Handle: RePEc:igg:jabim0:v:4:y:2013:i:4:p:35-47
    as

    Download full text from publisher

    File URL: http://services.igi-global.com/resolvedoi/resolve.aspx?doi=10.4018/ijabim.2013100103
    Download Restriction: no
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:igg:jabim0:v:4:y:2013:i:4:p:35-47. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Journal Editor (email available below). General contact details of provider: https://www.igi-global.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.